Total nonsense.
The PEA was from 2023 and was based on a weighted average spodumene concentrate price of US$1,699t/CIF SC5.5 and US$927t/CIF SC3.
The DFS will be made at a time when Lithium prices are way lower.
I doubt they'll even use Lithium prices which are 50% of those used in the PEA.
So the NPV will be substantially lower than in the PEA.
- Forums
- Charts
- LRS General Discussion
Total nonsense. The PEA was from 2023 and was based on a...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LRS (ASX) to my watchlist
|
|||||
Last
12.5¢ |
Change
0.015(13.6%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
12.0¢ | 13.0¢ | 12.0¢ | $897.7K | 7.352M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 1448702 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 1958261 | 45 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 1494332 | 0.125 |
26 | 1169240 | 0.120 |
19 | 1623327 | 0.115 |
36 | 1391478 | 0.110 |
22 | 1272091 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 2047921 | 48 |
0.135 | 1346688 | 20 |
0.140 | 737273 | 15 |
0.145 | 479265 | 11 |
0.150 | 256368 | 11 |
Last trade - 11.52am 14/08/2024 (20 minute delay) ? |
Featured News
LRS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online